These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22297643)

  • 21. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
    Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ
    Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in patients with hypersensitivity to mosquito bites.
    Asada H; Saito-Katsuragi M; Niizeki H; Yoshioka A; Suguri S; Isonokami M; Aoki T; Ishihara S; Tokura Y; Iwatsuki K; Miyagawa S
    J Invest Dermatol; 2005 Nov; 125(5):956-61. PubMed ID: 16297196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
    Umeki Y; Ikeda M; Nakahara W; Asako M; Matsuoka Y; Terakawa T; Matsunaga H; Tadokoro R; Sekiguchi M; Matsui T; Oka K; Higuchi K; Sawada A; Inoue M; Ueda S
    Rinsho Ketsueki; 2023; 64(3):209-213. PubMed ID: 37019675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of latent Epstein-Barr virus infection with hydroa vacciniforme.
    Iwatsuki K; Xu Z; Takata M; Iguchi M; Ohtsuka M; Akiba H; Mitsuhashi Y; Takenoshita H; Sugiuchi R; Tagami H; Kaneko F
    Br J Dermatol; 1999 Apr; 140(4):715-21. PubMed ID: 10233328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypersensitivity to mosquito bites and hydroa vacciniforme].
    Iwatsuki K; Yamamoto T; Tsuji K
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():657-61. PubMed ID: 16615554
    [No Abstract]   [Full Text] [Related]  

  • 28. Production of proinflammatory cytokines without invocation of cytotoxic effects by an Epstein-Barr virus-infected natural killer cell line established from a patient with hypersensitivity to mosquito bites.
    Suzuki D; Tsuji K; Yamamoto T; Fujii K; Iwatsuki K
    Exp Hematol; 2010 Oct; 38(10):933-44. PubMed ID: 20600581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders.
    Nitta Y; Iwatsuki K; Kimura H; Kojima S; Morishima T; Tsuji K; Oono T
    Eur J Dermatol; 2005; 15(6):503-6. PubMed ID: 16280311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.
    Tsuge I; Morishima T; Morita M; Kimura H; Kuzushima K; Matsuoka H
    Clin Exp Immunol; 1999 Mar; 115(3):385-92. PubMed ID: 10193407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basophil activation by mosquito extracts in patients with hypersensitivity to mosquito bites.
    Sakakibara Y; Wada T; Muraoka M; Matsuda Y; Toma T; Yachie A
    Cancer Sci; 2015 Aug; 106(8):965-71. PubMed ID: 25990049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
    Xu Z; Lian S
    Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases.
    Zhang Y; Liu Y; Xu J; Liang Y; Xu Z
    Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
    Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
    Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
    Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
    Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
    Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-associated T/natural killer-cell lymphomas in the elderly: the first consensus meeting in Kofu 2013.
    Hamada T; Nakamura S; Ko YH; Yoshino T; Ohshima K; Matsuzawa T; Miura K; Takahashi T; Nomura H; Hoshino T; Suzuki D; Shimada S; Iwatsuki K
    J Dermatol; 2014 Jan; 41(1):40-2. PubMed ID: 24438143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
    Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F
    Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmacytoid (CD68+CD123+) monocytes may play a crucial role in the pathogenesis of hydroa vacciniforme: a case report.
    Varughese N; Petrella T; Singer M; Carlson JA
    Am J Dermatopathol; 2009 Dec; 31(8):828-33. PubMed ID: 19730083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.